Literature DB >> 15009131

Risk factors for dopaminergic neuron loss in human alpha-synuclein transgenic mice.

M J Thiruchelvam1, J M Powers, D A Cory-Slechta, E K Richfield.   

Abstract

Genetic background, pesticide exposure, age, gender, diet and lifestyle are implicated risk factors in Parkinson's disease. We demonstrate dopamine neuron loss and other features of Parkinsonism based on the interaction of several of these human risk factors in transgenic mice expressing human alpha-synuclein. Mice expressing different forms of human alpha-synuclein had progressive declines in locomotor activity and abnormal responses to apomorphine that were modified by transgenic status. Stereological counts of tyrosine hydroxylase-positive neurons significantly declined with age only in the transgenic lines, consistent with a constant or decreasing risk, with the line expressing a double-mutant form of human alpha-synuclein more severely affected than the line expressing wild-type human alpha-synuclein. Treatment with Mn2+-ethylenebisdithiocarbamate and paraquat resulted in significantly greater effects in the double-mutant line than the other lines. Inclusions were not identified in the transgenic lines. Overexpression of human alpha-synuclein had adverse effects on substantia nigra pars compacta dopaminergic neurons that were modified by risk factors interacting in humans, including human alpha-synuclein mutations, ageing, and exposure to pesticides.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009131     DOI: 10.1111/j.0953-816x.2004.03139.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  57 in total

1.  Biochemical and morphological consequences of human α-synuclein expression in a mouse α-synuclein null background.

Authors:  Kavita Prasad; Elizabeth Tarasewicz; Pamela A Ohman Strickland; Michael O'Neill; Stephen N Mitchell; Kalpana Merchant; Samnang Tep; Kathryn Hilton; Akash Datwani; Manuel Buttini; Sarah Mueller-Steiner; Eric K Richfield
Journal:  Eur J Neurosci       Date:  2011-01-28       Impact factor: 3.386

Review 2.  Genetically engineered mouse models of Parkinson's disease.

Authors:  Donna M Crabtree; Jianhua Zhang
Journal:  Brain Res Bull       Date:  2011-08-03       Impact factor: 4.077

3.  The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection.

Authors:  Corrado Corti; Giuseppe Battaglia; Gemma Molinaro; Barbara Riozzi; Anna Pittaluga; Mauro Corsi; Manolo Mugnaini; Ferdinando Nicoletti; Valeria Bruno
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

4.  Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism.

Authors:  Timothy J Collier; Jack Lipton; Brian F Daley; Stephane Palfi; Yaping Chu; Caryl Sortwell; Roy A E Bakay; John R Sladek; Jeffrey H Kordower
Journal:  Neurobiol Dis       Date:  2007-01-23       Impact factor: 5.996

5.  Lithium protects against oxidative stress-mediated cell death in α-synuclein-overexpressing in vitro and in vivo models of Parkinson's disease.

Authors:  Yong-Hwan Kim; Anand Rane; Stephanie Lussier; Julie K Andersen
Journal:  J Neurosci Res       Date:  2011-06-24       Impact factor: 4.164

6.  Mitochondrial permeability transition pore regulates Parkinson's disease development in mutant α-synuclein transgenic mice.

Authors:  Lee J Martin; Samantha Semenkow; Allison Hanaford; Margaret Wong
Journal:  Neurobiol Aging       Date:  2013-11-16       Impact factor: 4.673

7.  Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression.

Authors:  P O Fernagut; C B Hutson; S M Fleming; N A Tetreaut; J Salcedo; E Masliah; M F Chesselet
Journal:  Synapse       Date:  2007-12       Impact factor: 2.562

8.  Conditional transgenic mice expressing C-terminally truncated human alpha-synuclein (alphaSyn119) exhibit reduced striatal dopamine without loss of nigrostriatal pathway dopaminergic neurons.

Authors:  João Paulo L Daher; Mingyao Ying; Rebecca Banerjee; Rebecca S McDonald; Myriam Dumas Hahn; Lichuan Yang; M Flint Beal; Bobby Thomas; Valina L Dawson; Ted M Dawson; Darren J Moore
Journal:  Mol Neurodegener       Date:  2009-07-24       Impact factor: 14.195

9.  Pro-survival role for Parkinson's associated gene DJ-1 revealed in trophically impaired dopaminergic neurons.

Authors:  Liviu Aron; Pontus Klein; Thu-Trang Pham; Edgar R Kramer; Wolfgang Wurst; Rüdiger Klein
Journal:  PLoS Biol       Date:  2010-04-06       Impact factor: 8.029

10.  Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1α transcription.

Authors:  Scott D Ryan; Nima Dolatabadi; Shing Fai Chan; Xiaofei Zhang; Mohd Waseem Akhtar; James Parker; Frank Soldner; Carmen R Sunico; Saumya Nagar; Maria Talantova; Brian Lee; Kevin Lopez; Anthony Nutter; Bing Shan; Elena Molokanova; Yaoyang Zhang; Xuemei Han; Tomohiro Nakamura; Eliezer Masliah; John R Yates; Nobuki Nakanishi; Aleksander Y Andreyev; Shu-ichi Okamoto; Rudolf Jaenisch; Rajesh Ambasudhan; Stuart A Lipton
Journal:  Cell       Date:  2013-11-27       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.